FDA: Yet Another Blood Pressure Medication Recall Due To Cancer Concerns - Forbes

is recalling all batches of their irbesartan tablets as well as their ...

[+] irbesartan plus hydrochlorothiazide (HCTZ) tablets.

Food and Drug Administration (FDA) has just announced yet another blood pressure medication recall due to unacceptably high levels of an impurity.

They’re recalling all batches of their irbesartan tablets as well as their irbesartan plus hydrochlorothiazide (HCTZ) tablets.

For example, in 2019 alone, I wrote three separate articles for Forbes on three different blood pressure medication recalls in January, March, and November of that year.

In fact, in the January 2019 article, I asked, “can you recall a year with more blood pressure medication recalls than 2018?” Each time the manufacturer may have changed but the song remained the same: some type of contaminant had reached unacceptable levels.

The irbesartan plus HCTZ tablet combines another blood pressure medication that works via a different mechanism with irbesartan.

Doctors don’t prescribe this medication just to mess with you.

Peeing more can help get rid of excess salt and fluid from your body, which, in turn, can reduce your blood pressure in a different manner.

Lupin had already discontinued in January 2021 the marketing both irbesartan alone and irbesartan plus HCTZ.

So, the recall doesn’t necessarily mean stop your irbesartan or irbesartan plus HCTZ immediately.

If you don’t have a doctor, yet are taking one of these prescription medications for blood pressure, ask yourself, “how the heck did that happen?” After all, you typically need a doctor to prescribe such a medication.

[+] different blood pressure medication recalls for impurities?

These blood pressure medication recalls are not simply a one-time occurrence or even a two-time occurrence.